XML 72 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
19. Restatement
12 Months Ended
Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
19. Restatement

The condensed consolidated financial statements contained in our Quarterly Report on Form 10-Q for the nine months ended September 30, 2014 requires restatement in order to correct errors related to the following:

 

The company determined that it had not properly accounted for the September 10, 2014 amendment to its articles of incorporation which affected the valuation of various classes of its common and preferred stock. This resulted in an understatement of the amounts recorded for stock based compensation in the third quarter of 2014. On September 10, 2014, an amendment to the corporation’s Articles of Incorporation was approved and accepted with respect to the Series B Preferred stock and Series C Preferred Stock. Per the amendment which was approved and adopted by the company’s board, the corporation shall not without first obtaining the approval, by written consent, as provided by law, of the holders of 2/3rds of the then outstanding shares of Series B Preferred stock or the Series C Preferred Stock, to increase or decrease, other than by redemption or conversion, the total number of authorized shares of the Series B Preferred stock or the Series C Preferred Stock, to effect an exchange, reclassification, or cancellation of all or a part of the Series B Preferred stock or the Series C Preferred Stock, but excluding a stock split, forward split or reverse stock split of the Corporation’s Common Stock, Series B Preferred stock or the Series C Preferred Stock, to effect an exchange, or create a right of exchange, of all or part of the shares of another class of shares into shares of Series B Preferred Stock or Series C Preferred stock, or to alter or change the rights, preferences or privileges of the shares of Series B Preferred Stock so as to affect adversely the shares of such series.

 

A valuation of the various classes of stock was performed by an independent third party to provide an estimated change in the fair value of each class affected by the amendment. The estimated change to the fair value of the various classes of stock is $721,207.

 

 

EPAZZ, INC.

CONSOLIDATED BALANCE SHEETS

       

 

   As Originally Reported       AS RESTATED 
   September 30, 2014   Adjustments   September 30, 2014 
Assets               
Current assets:               
Cash  $71,963   $   $71,963 
Accounts receivable, net   256,617        256,617 
Other current assets   131,392        131,392 
Total current assets   459,972        459,972 
                
Property and equipment, net   115,470        115,470 
Intangible assets, net   451,391        451,391 
Goodwill   1,355,361        1,355,361 
                
Total assets  $2,382,194   $   $2,382,194 
                
                
Liabilities and Stockholders' Equity (Deficit)               
Current liabilities:               
Dividends payable  $   $   $ 
Accounts payable   339,540        339,540 
Accrued expenses   213,022        213,022 
Accrued expenses, related parties            
Deferred revenue   592,408        592,408 
Lines of credit   83,260        83,260 
Current maturities of capital lease obligations payable   7,031        7,031 
Current maturities of notes payable, related parties ($1,066,073 currently in default)   1,186,618        1,186,618 
Convertible debts, net of discounts of $131,774 and $105,300, respectively ($60,674 currently in default)   152,275        152,275 
Current maturities of long term debts   809,177        809,177 
Derivative Liabilities            
Total current liabilities   3,383,331        3,383,331 
                
Notes payable, related parties            
Convertible debts, net of discounts of $0 and $4,283, respectively            
Long term debts, net of current maturities   911,467        911,467 
Total liabilities   4,294,798        4,294,798 
                
Stockholders' equity (deficit):               
Convertible preferred stock, Series A, $0.0001 par value, 1,000 shares authorized, 1,000 shares issued and outstanding            
Convertible preferred stock, Series B, $0.0001 par value, 1,000 shares authorized, 1,000 shares issued and outstanding            
Convertible preferred stock, Series C, $0.0001 par value, 3,000,000,000 shares authorized, 2,932,755,533 shares issued and outstanding   294,372        294,372 
Common stock, Class A, $0.0001 par value, 9,000,000,000 shares authorized, 37,557,842 and 346,836 shares issued and outstanding, respectively   721,338        721,338 
Convertible common stock, Class B, $0.0001 par value, 60,000,000 shares authorized, 23,000,000 and 10,500,000 shares issued and outstanding, respectively   2,300        2,300 
Additional paid in capital   9,290,110    721,207    10,011,317 
Stockholders' payable, consisting of 19,000,000 shares of Series C Convertible Preferred Stock and 28,875,000 shares of Class A Common Stock             
Stockholders' receivable, consisting of -0- and 20,000,000 shares of Class A Common Stock, respectively            
Accumulated deficit   (12,220,724)   (721,207)   (12,941,931)
Total stockholders' equity (deficit)   (1,912,604)       (1,912,604)
                
Total liabilities and stockholders' equity (deficit)  $2,382,194   $   $2,382,194 

 

 

EPAZZ, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

         

 

   For the Three Months Ending September 30, 2014 
   As Originally Reported   Adjustments   As RESTATED 
             
Revenue  $361,150   $   $361,150 
                
Expenses:               
General and administrative   113,308        113,308 
Salaries and wages   209,667    721,207    930,874 
Depreciation and amortization   55,156        55,156 
Bad debts (recoveries)   30,813        30,813 
Total operating expenses   408,944    721,207    1,130,151 
                
Net operating loss   (47,794)   (721,207)   (769,001)
                
Other income (expense):               
Interest Income            
Interest expense   (194,583)       (194,583)
Loss on debt modifications, related parties            
Other Income / (Expense)   19,251         19,251 
Change in derivative liabilities            
Total other income (expense)   (175,332)       (175,332)
                
Net loss  $(223,126)  $(721,207)  $(944,333)
                
Weighted average number of common shares outstanding - basic and fully diluted   7,052,068,854    7,052,068,854    7,052,068,854 
                
Net loss per share - basic and fully diluted  $(0.00)  $(0.00)  $(0.00)

 

EPAZZ, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the Nine Months Ending September 30, 2014 
   As Originally Reported   Adjustments   As RESTATED 
             
Revenue  $941,227   $   $941,227 
                
Expenses:               
General and administrative   683,447        683,447 
Salaries and wages   2,654,666    721,207    3,375,873 
Depreciation and amortization   152,711        152,711 
Bad debts (recoveries)   25,551        25,551 
Total operating expenses   3,516,375    721,207    4,237,582 
                
Net operating loss   (2,575,148)   (721,207)   (3,296,355)
                
Other income (expense):               
Interest income   55        55 
Interest expense   (1,212,360)       (1,212,360)
Loss on debt modifications, related parties   (172,864)       (172,864)
Other Income / (Expense)   19,251         19,251 
Change in derivative liabilities   (777,664)       (777,664)
Total other income (expense)   (2,143,582)       (2,143,582)
                
Net loss  $(4,718,730)  $(721,207)  $(5,439,937)
                
Weighted average number of common shares outstanding - basic and fully diluted   5,563,139,967    5,563,139,967    5,563,139,967 
                
Net loss per share - basic and fully diluted  $(0.00)  $(0.00)  $(0.00)

 

 

 

EPAZZ, INC.

 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

         

 

   As Originally Reported       As RESTATED 
   September 30, 2014   Adjustments   September 30, 2014 
Cash flows from operating activities               
Net loss  $(4,718,730)  $(721,207)  $(5,439,937)
Adjustments to reconcile net loss to net cash used in operating activities:               
Bad debts (recoveries)   25,551        25,551 
Depreciation and amortization   41,452        41,452 
Impairment of intangible assets   111,259        111,259 
Amortization of deferred financing costs   317,789        317,789 
Amortization of discounts on convertible debts   495,683        495,683 
Loss on debt modifications, related parties   172,864        172,864 
Loss on default provisions of convertible debt   77,375        77,375 
Change in fair market value of derivative liabilities   777,664        777,664 
Stock based compensation issued for services   93,056        93,056 
Stock based compensation issued for services, related parties   2,243,402    721,207    2,964,609 
Decrease (increase) in assets:               
Accounts receivable   1,130        1,130 
Other current assets   48,035        48,035 
Increase (decrease) in liabilities:              
Accounts payable   (395,307)       (395,307)
Accrued expenses   81,049        81,049 
Accrued expenses, related parties   57,450        57,450 
Deferred revenues   270,277        270,277 
Net cash provided by (used in) operating activities   (300,001)       (300,001)
                
Cash flows from investing activities               
Cash acquired in merger   736        736 
Purchase of equipment   (43,512)       (43,512)
Acquisition of subsidiaries   (582,945)       (582,945)
Net cash used in investing activities   (625,721)       (625,721)
                
Cash flows from financing activities               
Payments on capital lease obligations payable   (10,392)       (10,392)
Proceeds from notes payable, related parties   774,524        774,524 
Repayment of notes payable, related parties   (82,879)       (82,879)
Proceeds from convertible notes            
Repayment of convertible notes   (1,500)       (1,500)
Proceeds from long term debts   582,206        582,206 
Repayment of long term debts   (472,841)       (472,841)
Net cash provided by financing activities   789,118        789,118 
                
Net increase (decrease) in cash   (136,604)       (136,604)
Cash - beginning   208,567        208,567 
Cash - ending  $71,963   $   $71,963 
                
Supplemental disclosures:               
Interest paid   187,563        187,563 
Income taxes paid            
                
Non-cash investing and financing activities:               
Acquisition of subsidiary in exchange for debt  $611,988   $   $611,988 
Value of shares issued for conversion of debt  $533,360   $   $533,360 
Value of shares issued for conversion of debt, related parties  $112,183   $   $112,183 
Shares issued for dividend payable  $11,000   $   $11,000 
Discount on derivatives  $422,240   $   $422,240 
 Beneficial conversion feature  $35,028   $   $35,028 
Deferred financing costs  $391,102   $   $391,102 
Value of derivative adjustment due to debt conversions  $1,199,904   $   $1,199,904 
Dividends payable declared  $   $   $